A Randomised Controlled Trial of Factor Replacement Therapy in Snake Bite Coagulopathy

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This proposal seeks funding to undertake a controlled trial of clotting factor replacement in snake bite coagulopathy after the administration of a neutralising dose of antivenom. The aim is to determine if factor replacement will result in a rapid return of clotting function in patients and therefore reduce the potential risk of major bleeding. This study will have international implications because globally snakebite coagulopathy is a major cause of morbidity and death like in Australia.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2010

Funding Scheme: NHMRC Project Grants

Funding Amount: $715,730.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical biochemistry - lipids

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

ELISA | coagulation disorders | envenomation | primary health care | therapy | toxinology | venom